Download references
CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer
-
* Corresponding author: Francisco J Esteva festeva@mdanderson.org
Breast Cancer Research 2007, 9:R87 doi:10.1186/bcr1836